Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob M Rowe

Showing results (11-20 of 275) with videos related to

Pageof 28
Sort By:
British Journal of Haematology|June 25, 2010
Prognostic factors in adult acute lymphoblastic leukaemiaJacob M Rowe
Blood|May 8, 2010
Getting to the root of (it) ALLJacob M Rowe
Best Practice & Research. Clinical Haematology|November 29, 2016
AML in 2016: Where we are now?Jacob M Rowe
Best Practice & Research. Clinical Haematology|March 7, 2006
Is there a role for consolidation therapy pre-transplantation?Jacob M Rowe
Hematology. American Society of Hematology. Education Program|December 17, 2009
Optimal induction and post-remission therapy for AML in first remissionJacob M Rowe
The Oncologist|December 13, 2007
Innovative approaches in the treatment and support of patients with acute myelogenous leukemiaJacob M Rowe
British Journal of Haematology|December 6, 2008
Optimal management of adults with ALLJacob M Rowe
Best Practice & Research. Clinical Haematology|December 6, 2021
Changing trends in the therapy of acute myeloid leukemiaJacob M Rowe
Best Practice & Research. Clinical Haematology|November 21, 2017
AML in 2017: Advances in clinical practiceJacob M Rowe
Best Practice & Research. Clinical Haematology|December 7, 2010
The evolving paradigm of prognostic factors in AML: Introduction to the Acute Leukemia Forum 2010Jacob M Rowe
Pageof 28

Showing results (11-20 of 275) with videos related to

Sort By:
Pageof 28
British Journal of Haematology|June 25, 2010
Prognostic factors in adult acute lymphoblastic leukaemiaJacob M Rowe
Blood|May 8, 2010
Getting to the root of (it) ALLJacob M Rowe
Best Practice & Research. Clinical Haematology|November 29, 2016
AML in 2016: Where we are now?Jacob M Rowe
Best Practice & Research. Clinical Haematology|March 7, 2006
Is there a role for consolidation therapy pre-transplantation?Jacob M Rowe
Hematology. American Society of Hematology. Education Program|December 17, 2009
Optimal induction and post-remission therapy for AML in first remissionJacob M Rowe
The Oncologist|December 13, 2007
Innovative approaches in the treatment and support of patients with acute myelogenous leukemiaJacob M Rowe
British Journal of Haematology|December 6, 2008
Optimal management of adults with ALLJacob M Rowe
Best Practice & Research. Clinical Haematology|December 6, 2021
Changing trends in the therapy of acute myeloid leukemiaJacob M Rowe
Best Practice & Research. Clinical Haematology|November 21, 2017
AML in 2017: Advances in clinical practiceJacob M Rowe
Best Practice & Research. Clinical Haematology|December 7, 2010
The evolving paradigm of prognostic factors in AML: Introduction to the Acute Leukemia Forum 2010Jacob M Rowe
Pageof 28